Sage Journals: Discover world-class research

Abstract

French

Antiinflammatory analgesics recently approved by the FDA for use in the United States are evaluated and compared with aspirin and other older agents. The drugs discussed are propionic acid derivatives, tolmetin, and sulindac. Indications, dosages, efficacy, side effects, cost, precautions, and interactions are discussed.

The propionic acid derivatives and tolmetin are structurally different from older drugs and provide new alternatives in the treatment of inflammatory disease and pain. Of these new agents, naproxen appears to be first choice.

Sulindac is the result of efforts to improve indomethacin. It possesses a longer duration of action, and it appears to cause fewer side effects.

Get full access to this article

View all access options for this article.

References

Brooks

Buchanan

WW.

In: Buchanan Dick eds. Recent advances in rheumatology. Part 2. Edinburgh, Churchill Livingston, 1976.

Huskisson

Four new antiinflammatory drugs: responses and variations. Br Med J 1976; 1: 1048–9.

Hill

HFH

Multi-centre double-blind cross-over trial comparing naproxen and aspirin in rheumatoid arthritis. Scand J Rheumatol (Suppl) 1973; 2: 176–81.

Diamond

Naproxen and aspirin in rheumatoid arthritis: a multicenter double-blind crossover comparison study. J Clin Pharmacol 1975; 15: 335–9.

Cochrane

GM.

A double-blind comparison of naproxen with indomethacin in osteoarthritis. Scand J Rheumatol (Suppl) 1973; 2: 89–93.

Lussier

Naproxen: a novel approach to dose-finding efficacy trials in rheumatoid arthritis. Clin Pharmacol Ther 1973; 14: 431–4.

Cuq

Experience francaise du traitement de la crise de goutte aigue par le naproxen. Scand J Rheumatol (Suppl) 1973; 2: 64–8.

Runkel

Nonlinear plasma level response to high doses of naproxen. Clin Pharmacol Ther 1974; 15: 261–6.

Lussier

Arsenault

Varady

Gastrointestinal microbleeding after aspirin and naproxen. Clin Pharmacol Ther 1978; 23: 402–7.

10.

Wilkens

Segre

EJ.

Combination therapy with naproxen and aspirin in rheumatoid arthritis. Arthritis Rheum 1976; 19: 677–82.

11.

Segre

Letter. N Engl J Med 1974; 291: 582.

12.

Blechman

Ibuprofen or aspirin in rheumatoid arthritis therapy. JAMA 1975; 233: 336–40.

13.

Hamaty

Comparison of ibuprofen and placebo for treatment of residual symptoms in gold-treated rheumatoid arthritis. J Rheumatol 1974; 1: 453–61.

14.

Godfrey

De la Cruz

Effect of ibuprofen dosage on patient response in rheumatoid arthritis. Arthritis Rheum 1975; 18 (2): 135–7.

15.

Hart

FD.

Pain in osteoarthrosis. Practitioner 1974; 212: 244–50.

16.

Goldberg

AAJ

The long-term benefits of ibuprofen in rheumatological practice. Interim report. Practitioner 1971; 207: 343–8.

17.

Stanaszek

WF.

Case studies in pharmacy practice: rheumatoid arthritis. US Pharmacist 1978; 3: 16.

18.

Thompson

Letter. Br Med J 1972; 4: 550.

19.

Committee on Safety of Medicines. Current Problems Series No. 1. (Sept.) 1975.

20.

Wade

Martindale: the extra pharmacopoeia. 27th ed. London: The Pharmaceutical Press, 1977: 191–3, 199–200, 211–14, 1823.

21.

Schmid

Culic

DD.

Antiinflammatory drugs and gastrointestinal bleeding: comparison of aspirin and ibuprofen. Paper presented at the VI Pan American Congress on Rheumatic Diseases. Toronto, (June) 1974.

22.

Huskisson

Treatment of rheumatoid arthritis with fenoprofen. Comparison with aspirin. Br Med J 1974; 1: 176–80.

23.

Ridolfo

Effects of fenoprofen and aspirin on GI microbleeding in man. Clin Pharmacol Ther 1973; 14: 226–30.

24.

Wojtulewski

Fenoprofen in treatment of osteoarthritis of hip and knee. Br Med J 1974; 2: 475–6.

25.

Bain

Tolmetin: an evaluation of a new preparation in the treatment of rheumatoid arthritis. Br J Clin Pract 1975; 29: 208–10.

26.

Brown

Results of a one-year trial of tolmetin in patients with rheumatoid arthritis. J Clin Pharmacol 1975; 15: 455–63.

27.

Clinoril in the management of many arthritic disorders. West Point, PA: Merck Sharp & Dohme, 1978.

28.

Cohen

Intestinal blood loss after a new antiinflammatory drug, sulindac. Clin Pharmacol Ther 1976; 20 (2): 238–40.

29.

Rooney

A clinical assessment in general practice of sulindac. Eur J Rheumatol Inflammation 1978; 1: 66–8.

30.

Dieppe

Sulindac in osteoarthrosis of the hip. Rheumatol Rehabil 1976; 15: 112–5.

31.

Duggan

The disposition of sulindac. Clin Pharmacol Ther 1977; 21: 326.

32.

Goodman

Gilman

The pharmacological basis of therapeutics. 5th ed. New York: MacMillan, 1975: 342.

33.

Package inserts.

34.

Castles

Multicenter comparison of naproxen and indomethacin in rheumatoid arthritis. Arch Intern Med 1978; 138: 362–6.

35.

Tse

Aspirin intolerance syndrome. Drug Intell Clin Pharm 1978; 12: 464–8.

36.

PPK

Esterman

MA.

Fenoprofen: inhibitor of prostaglandin synthesis. Prostaglandins 1974; 6: 107–13.

37.

Brogden

Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. Drugs 1975; 9: 326.

38.

Shen

Ham

Cirillo

Zanetti

Structure-activity relationship of certain prostaglandin synthetase inhibitors. In: Robinson

Vane

eds. Prostaglandin synthetase inhibitors. New York: Raven Press, 1974: 19–31.

39.

Lundstrom

Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors — a promising therapeutic alternative. Acta Obstet Gynecol Scand 1978; 57: 421–8.

40.

Green

The effect of a new nonsteroidal antiinflammatory agent, sulindac, on platelet function. Thromb Res 1977; 10: 283–9.

41.

Cressman

Pharmacokinetics of tolmetin, a new antiinflammatory agent. Clin Pharmacol Ther 1974; 15: 203.

42.

Segre

Interaction of naproxen and aspirin in the rat and in man. Scand J Rheumatol Suppl 1973; 2: 37–42.

43.

Sunshine

Laska

Oral analgesic studies of propoxyphene HCl, Lilly 61169, and a combination. Clin Pharmacol Ther 1971; 12: 302.

44.

Runkel

Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. J Pharm Sci 1972; 61: 703–7.

45.

Kaiser

Vangiessen

GJ.

GLC determination of ibuprofen [(pL)-2-(p-isobutylphenyl) propionic acid] in plasma. J Pharm Sci 1974; 63: 219–21.

Recently Approved Alternatives to Aspirin

Abstract

Get full access to this article

References